Aptevo Therapeutics Inc

Other US APVTW

NoneUSD
-(-%)

Last update at 2024-04-09T03:57:38.385164Z

Day Range

--
LowHigh

52 Week Range

0.00180.07
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap0.00000M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2020-12-31 2019-12-31
Type yearly yearly
Date 2020-12-31 2019-12-31
Income before tax -17.75000M -44.69800M
Minority interest - -
Net income -17.75000M -40.44800M
Selling general administrative -13.95100M 25.34M
Selling and marketing expenses - -
Gross profit 4.31M 12.50M
Reconciled depreciation - -
Ebit -27.49400M -44.69800M
Ebitda -17.75000M -
Depreciation and amortization 9.74M -
Non operating income net other - -2.10200M
Operating income -27.49400M -42.59600M
Other operating expenses 31.80M -
Interest expense - 0.00000M
Tax provision - -
Interest income - -
Net interest income - -
Extraordinary items - -
Non recurring - -
Other items - -
Income tax expense - -
Total revenue 4.31M 32.42M
Total operating expenses -31.80300M 55.09M
Cost of revenue - 19.93M
Total other income expense net 9.74M -
Discontinued operations - 4.25M
Net income from continuing ops - -44.69800M
Net income applicable to common shares - -40.44800M
Preferred stock and other adjustments - -
Breakdown 2020-12-31 2019-12-31
Type yearly yearly
Date 2020-12-31 2019-12-31
Total assets 53.55M 53.41M
Intangible assets - 4.42M
Earning assets - -
Other current assets 7.29M 4.39M
Total liab 36.95M 41.57M
Total stockholder equity 16.59M 11.84M
Deferred long term liab - -
Other current liab 9.54M 1.81M
Common stock 0.05M 0.04M
Capital stock - -
Retained earnings - -167.85600M
Other liab - -
Good will - -
Other assets - -
Cash 39.98M 12.45M
Cash and equivalents - -
Total current liabilities 14.54M 38.24M
Current deferred revenue - -
Net debt -34.97900M -
Short term debt 5.00M 19.86M
Short long term debt - -
Short long term debt total 5.00M -
Other stockholder equity 16.55M -
Property plant equipment - 3.95M
Total current assets 47.26M 30.00M
Long term investments - -
Net tangible assets - 7.42M
Short term investments - -
Net receivables - 7.02M
Long term debt - -
Inventory - 6.14M
Accounts payable - 16.57M
Total permanent equity - -
Noncontrolling interest in consolidated entity - -
Temporary equity redeemable noncontrolling interests - -
Accumulated other comprehensive income - -
Additional paid in capital - -
Common stock total equity - 0.04M
Preferred stock total equity - -
Retained earnings total equity - -167.85600M
Treasury stock - -
Accumulated amortization - -
Non currrent assets other 0.75M 15.05M
Deferred long term asset charges - -
Non current assets total 6.28M 23.41M
Capital lease obligations - -
Long term debt total - -
Breakdown 2019-12-31
Type yearly
Date 2019-12-31
Investments -
Change to liabilities 0.94M
Total cashflows from investing activities 4.10M
Net borrowings -
Total cash from financing activities 20.15M
Change to operating activities -
Net income -40.44800M
Change in cash -18.13700M
Begin period cash flow -
End period cash flow -
Total cash from operating activities -42.38300M
Issuance of capital stock -
Depreciation 2.23M
Other cashflows from investing activities 4.25M
Dividends paid -
Change to inventory -4.35400M
Change to account receivables -
Sale purchase of stock -
Other cashflows from financing activities 20.15M
Change to netincome -2.65200M
Capital expenditures 0.15M
Change receivables -1.80200M
Cash flows other operating 3.70M
Exchange rate changes -
Cash and cash equivalents changes -18.13700M
Change in working capital -
Stock based compensation -
Other non cash items -
Free cash flow -

Peer Comparison

Sector: Other Industry: Other

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
APVTW
Aptevo Therapeutics Inc
- -% - - - - -
FREJO
Federal Home Loan Mortgage Corporation PFD 5.1% SAL
- -% 17.95 - - - -
SFB
Stifel Financial Corporation 5.20% Senior Notes due 2047
-0.12 0.57% 20.75 - - - -
JSM
Navient Corporation SR NT 6% 121543
-0.34 1.82% 18.29 15.90 - - -
BHFAL
Brighthouse Financial Inc
-0.3 1.48% 19.97 - - - -

Reports Covered

Stock Research & News

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.